APPLICATION OF NON-TEST METHODS FOR CHANEL ESTIMATION

by M. L. Maslakov, M. S. Smal
Published 2018-08-01

Role of the FGFR3 gene mutation status in predicting progression of non-muscle-invasive bladder cancer

by A. I. Rolevich, M. P. Smal, S. A. Krasnyi, R. I. Goncharova
Published 2015-09-01

The opposite association of HRAS and KRAS mutations with clinical variables of bladder cancer

by M. P. Smal, A. I. Rolevich, T. N. Nabebina, S. A. Krasny, R. I. Goncharova
Published 2015-12-01